Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP263308.RA9lThQFPp_gHvY_fDI2qBjRxVG2ttkazxUP0u314MyzE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP263308.RA9lThQFPp_gHvY_fDI2qBjRxVG2ttkazxUP0u314MyzE130_assertion type Assertion NP263308.RA9lThQFPp_gHvY_fDI2qBjRxVG2ttkazxUP0u314MyzE130_head.
- NP263308.RA9lThQFPp_gHvY_fDI2qBjRxVG2ttkazxUP0u314MyzE130_assertion description "[The siRNA-mediated knockdown of bcl-2 leads to pronounced anti-tumor effects in a pancreatic cancer model, especially in combination with chemotherapy even at otherwise ineffective concentrations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP263308.RA9lThQFPp_gHvY_fDI2qBjRxVG2ttkazxUP0u314MyzE130_provenance.
- NP263308.RA9lThQFPp_gHvY_fDI2qBjRxVG2ttkazxUP0u314MyzE130_assertion evidence source_evidence_literature NP263308.RA9lThQFPp_gHvY_fDI2qBjRxVG2ttkazxUP0u314MyzE130_provenance.
- NP263308.RA9lThQFPp_gHvY_fDI2qBjRxVG2ttkazxUP0u314MyzE130_assertion SIO_000772 21605072 NP263308.RA9lThQFPp_gHvY_fDI2qBjRxVG2ttkazxUP0u314MyzE130_provenance.
- NP263308.RA9lThQFPp_gHvY_fDI2qBjRxVG2ttkazxUP0u314MyzE130_assertion wasDerivedFrom befree-20150227 NP263308.RA9lThQFPp_gHvY_fDI2qBjRxVG2ttkazxUP0u314MyzE130_provenance.
- NP263308.RA9lThQFPp_gHvY_fDI2qBjRxVG2ttkazxUP0u314MyzE130_assertion wasGeneratedBy ECO_0000203 NP263308.RA9lThQFPp_gHvY_fDI2qBjRxVG2ttkazxUP0u314MyzE130_provenance.